📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Blood gene expression changes after Risperidone treatment in an antipsychotic-naïve cohort of first episode of psychosis patients. (2020)

First Author: Xavier G

Attributed to: Newton001: Biomarkers of treatment naive psychosis. funded by Newton Fund

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.schres.2020.03.033

PubMed Identifier: 32247745

Publication URI: http://europepmc.org/abstract/MED/32247745

Type: Journal Article/Review

Volume: 220

Parent Publication: Schizophrenia research

ISSN: 0920-9964